Skip to main content

Table 1 Patient characteristics

From: HO-1 promotes resistance to an EZH2 inhibitor through the pRB-E2F pathway: correlation with the progression of myelodysplastic syndrome into acute myeloid leukemia

Patient characteristics 
Characteristic(n, %)
Age (years)58
 <7040 (69%)
 ≥7018 (21%)
Sex58
 Male44 (76%)
 Female14 (24%)
WHO classification58
 RA/RAS10 (17%)
 RCMD/RSCMD14 (24%)
 RAEB-I9 (16%)
 RAEB-II22 (38%)
 RAEB-t/AML3 (5%)
WPSS risk group58
 Very low6 (10%)
 Low9 (16%)
 Intermediate14 (24%)
 High13 (22%)
 Very high16 (28%)